ISRCTN74681449已完成不适用
Efficacy of Quetiapine in Parkinson's Psychosis
King's College London (UK)0 个研究点目标入组 60 人开始时间: 2005年9月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Hallucinations, delusions of a severity >3/7 on the Brief Psychiatric Rating Scale, 2. Diagnosis of Parkinson's which meets UKPD Society Brain Bank criteria
排除标准
- •1. Anti-psychotic medication in the preceding 3 months
- •2. Any contra-indication to quetiapine
- •3. Any important drug interactions
- •4. Major concomitant medical illness
- •5. History of uncontrolled diabetes or hypertension
- •6. Changes in medication in the last 14 days
研究者
相似试验
进行中（未招募）
不适用
The Effect of the Atypical Antipsychotic Quetiapine in the Treatment of Postpartum Depressive Disorders with or without Psychotic SymptomsPostpartum depressive disorders with or without psychotic symptomsEUCTR2006-006427-39-DEAstraZeneca GmbH
进行中（未招募）
不适用
Quetiapine in the treatment of psychotic depression. A pilot study(QTP-Dep-Bo) - (QTP-Dep-Bo)EUCTR2008-000041-60-DEWL Universitätsklinik für Psychiatrie Bochum
进行中（未招募）
不适用
Effects of QuetiapineXR in schizophrenic patients with cannabis abuseand/or cannabis induced psychosis -pilot studycannabis induced psychosis/schizophrenic patients with cannabis abuseEUCTR2008-000766-23-DEMedical School Hannover, Department of Psychiatry, Socialpsychiatry and Psychotherapy
已完成
3 期
Effect of Quetiapine in Preventing Delirium in ICU Patientspatient admitted to the intensive care unit.Delirium due to known physiological conditionIRCT20180520039739N5Esfahan University of Medical Sciences98
进行中（未招募）
不适用
Quetiapine induced neuroplasticity in schizophrenic patients: A combined TMS and VBM studyEUCTR2007-000545-35-DEMedical Institutions of the District Oberpfalz/Bayern (MedBO GmbH)